Skip to content
Clinical Trials – home
HungaryBack to Hungary

Clinical trials in Vac – page 17

1 101 clinical trials in Vac, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.

Vac at a glance
1 101
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 101 trials in Vac

Open in trial search

A Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Amivantamab
  • Sponsor:Janssen - Cilag International

A study testing tulmimetostat with darolutamide or abiraterone in patients with metastatic hormone-sensitive prostate cancer

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Novartis Pharma AG

Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Ospedale Pediatrico Bambino Gesu

Schizophrenia

Recruiting

Long-Term Safety Study of Direclidine in Adults with Schizophrenia

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Direclidine
  • Sponsor:Neurocrine Biosciences Inc.

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

A Study of Puxitatug Samrotecan Compared to Chemotherapy for Patients with Advanced Endometrial Cancer After Previous Platinum and Immunotherapy Treatment

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:AZD8205
  • Sponsor:Astrazeneca AB

A study testing intranasal esketamine compared to midazolam for rapidly reducing symptoms of major depressive disorder in adolescents with suicidal thoughts or behavior

Registered drug
Countries:HungaryHungary
  • Participants:0–17 years
  • Substances:Esketamine
  • Sponsor:Janssen - Cilag International

A Study of MK-1084 and Drug Combination Versus Pembrolizumab and Chemotherapy for Adults with Advanced Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Schizophrenia

Recruiting

A study testing direclidine compared to placebo in adults with schizophrenia who need hospital care

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Direclidine
  • Sponsor:Neurocrine Biosciences Inc.

A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Brexanolone caprilcerbate
  • Sponsor:Seaport Therapeutics Inc.

A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:ADX-324
  • Sponsor:Adarx Pharmaceuticals Inc.

A Study of IMVT-1402 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy to Prevent Disease Relapse

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Other cities in Hungary

The busiest research cities in the country

All 73 cities in Hungary

Clinical research in Vac

What the registry says about research in the country

01 Inflammatory Bowel Disease Research

Extensive clinical trials focusing on Ulcerative Colitis and Crohn's Disease treatments, evaluating innovative therapies including zasocitinib and mirikizumab for long-term disease management.

  • Moderate to Severe UC Treatment
  • Crohn's Disease Management
  • Bowel Urgency Studies

Multiple studies examining both short-term and extended treatment outcomes for inflammatory bowel conditions.

02 Neurological Disorders

Research initiatives targeting acute ischemic stroke and migraine treatments, including studies of innovative compounds like redasemtide and atogepant.

  • Stroke Prevention
  • Acute Migraine Treatment
  • Post-Stroke Care

Focused investigations on reducing stroke risk and improving acute migraine management outcomes.

03 Therapeutic Innovations

Development of novel treatments including biosimilar studies and evaluation of new molecular entities for chronic inflammatory conditions.

  • Biosimilar Development
  • Long-term Safety Studies
  • Clinical Remission Research

Comprehensive assessment of treatment efficacy and safety profiles across multiple therapeutic areas.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.